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F9 teratocarcinoma antigen is expressed normally on embryos which are homozygous recessive for 
each of 4 mutations lethal in early development, including t 12. Homozygosity for two post-implanta- 
tion T-region developmental lethal genes, t w5 and T Orl, may alter F9 antigen expression but the 
results were not definitive. In addition, the time of appearance of the antigen may be affected by some 
of the genotypes. 
INTRODUCTION 
The concept that cell surfaces contain information used for communication between 
cells during morphogenesis is an old one. During recent decades antigens have been sought 
as the counterparts of  such cell surface molecules. In particular, they have been found 
with spectacular success among lymphocytes where they have clearly been shown to be 
markers of  differentiation (Hood et al., 1977). 
There has been less direct evidence for such cell surface markers in embryogenesis. One 
antigen that is expressed in early embryos and which, because of  its association with 
developmental mutants, has been reported to have a role in morphogenesis is the F9 
teratocarcinoma antigen. The class of  teratocarcinoma antigens which cross-react with 
embryos was initially found by Edidin and co-workers who raised antisera in rabbits 
directed against mouse teratocarcinoma (Edidin et al., 1971). Artzt and co-workers pro- 
duced a syngeneic antiserum against cell lines from such a tetracarcinoma using irradiated 
cells from a nullipotent embryonal carcinoma cell line, F9 (Artzt et al., 1973). This anti- 
serum (anti-F9) also reacted with preimplantation embryos and male germ line cells. 
Developmental lethal mutations of  the T-region of  the mouse were reported to alter 
F9 antigenic reactivity (Artzt et al., 1974). This complex region on the proximal portion 
of  chromosome 17 includes loci with effects on sperm function, chromosomal exchanges, 
interaction with a single dominant mutation to affect tail length, and embryonic lethality. 
The embryonic lethality falls into six complementation groups, each with its own charac- 
teristic stage of  developmental delay. It was suggested that the structural gene for the F9 
antigen was located in the T-region of  chromosome 17 of  the mouse since 1), twice as 
many sperm cells from a +/t w32 mouse were needed to remove a standard amount o f  F9 
antiserum when compared to sperm from a +/+ mouse (Artzt et al., 1974) and 2) expres- 
sion of  the F9 antigen appeared to segregate among the progeny of  crosses producing 
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tw32/t w32 or tws/t ws embryos (Kemler et al., 1976). The number of  negative embryos 
approximated to the expected number of  t-allele homozygotes.  Originally, it was said that 
t 12 homozygous embryos expressed no F9 antigen. However, the Artzt  group now 
believe that t~2/t 12 embryos show less F9 antigen but  that 'regardless of  t genotype,  all 
four-cell to morula stage embryos display at least some F9 antigen' (Marticorena et al., 
1978). Since a variety of  factors could cause such discrepancies, we have investigated the 
expression of  F9 antigen in normal pre-implantation embryos and embryos homozygous 
for lethal mutat ions at a variety of  loci, using three different antisera, in order to further 
the understanding of  genetic effects on cell surfaces and early development. 
MATERIALS AND METHODS 
Mutant mouse strains 
The mouse mutants are maintained as inbred lines and are designated: (1) Tit z2, (2) 
Tit w5 (balanced lethal lines since TIT and tn/t n die in utero), (3) T°r l /+ ,  (4) cCh/c2Sn, 
TABLE 1 
Developmental lethal mutations studied 





stage normal morphology of mutant 
littermate 
Pre-implantation lethals 
c 25 Albino 7 21 days 
Os Oligo-syn- 8 4 days 
dactylism 
t 12 T-region 17 321- days 
Post-implantation lethals 
c 6H Albino 7 7 days 
T Orl T-region 17 7 days 
Morulae Arrested at 2-6 cell stage 
Expanded or Retarded blastocyst 
hatched 
blastocysts 
Blastocysts Morulae b 
Egg cylinder with 
primitive 
streak 
Egg cylinder with 
primitive 
streak 
t w5 T-region 17 7 days Egg cylinder with 
primitive 
streak 
Very retarded egg cylinder 
and primitive streak and 
nearly absent ecto- 
placental cone 
Total arrest of egg cylinder 
only parietal yolk sac and 
trophoblastic giant cells 
differentiate 
Very similar to T Orl 
a This applies to gross identification in unfixed material. Identification can be earlier in certain his- 
tological or cytological preparations. 
b Some overlap with normal embryos. 
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(5) cch/c 6H, and (6) +/Os. The distinguishing characteristics of these developmental lethal 
mutations are given in Table 1. The first, fourth and fifth were obtained from Dr. S. 
Gluecksohn-Waelsch, the third from J.L. Guenet, the sixth from the Jackson Laboratory, 
the second from Dr. William F. Dove, and the last from Dr. R. Pedersen. Embryos were 
used directly from lines 4 - 6  without any outcrosses. Control embryos (+/+) were derived 
from a variety of inbred strains while outcrosses of  lines 1 and 2 to A/J or C57BL/10J 
produced the necessary T/+ and +It types. 
Preparation and absorption of antisera 
129/Sv mice were immunized by the intraperitoneal route, weekly for three weeks, 
and then bi-weekly with five more injections, using 1 -2  × 10 6 F9 cells grown in tissue 
culture, harvested in EDTA, suspended in Hank's balanced salt solution, and irradiated 
with a cesium source'(2000 rad). One week after the final immunization, the mice were 
inoculated with 10 s Ehrlich ascites cells to produce large amounts of antiserum (Herman 
and Engle, 1957). The resulting ascitic fluid had somewhat lower titers than anti-F9 anti- 
serum; there was 50% killing of F9 cells in the microcytotoxicity test (Artzt et al., 1973) 
at a 1/300 dilution. Two additional anti-F9 sera were obtained from Dr. M. Edidin: (1) 
AS-7, a 129/J anti-F9 serum prepared as above but with F9 cells obtained from Karen 
Artzt, and (2) AS-9 (CBA/HN X 129)F1 anti-F9 serum, the CBA/HN strain having low 
natural immunity to tumor ceils. Both sera showed precipitin lines with fetal calf sera; 
these were removed by a 1 : 1 absorption with fetal calfsera. All anti-F9 sera were routinely 
absorbed with equal volumes of mouse spleen cells or on primitive yolk sac (PYS) tumor 
(No. SV 74115-230 from Dr. L. Stevens). 
Rabbit anti-mouse IgG serum labeled with fluorescein isothiocyanate (FITC) was pur- 
chased from Miles Laboratories (lot No. DS302). Rabbit anti-mouse IgM serum labeled 
with FITC was purchased from Cappel Laboratories (lot No. 11925) and was absorbed as 
described for rabbit and mouse IgG. These sera were absorbed on mouse liver suspension 
at a ratio of 2 vols. of packed cells to 1 vol. of conjugated serum before use. Liver, spleen, 
or PYS tumor were finaly diced, dissociated with a No. 16 mesh screen, and brought to 
about 10 vols. in Dulbecco's (Ca2+-Mg2+)-free phosphate-buffered saline. The suspension 
was allowed to settle (1 g) for 10 min to remove large fragments and the cells in the 
supernatant were pelleted by centrifugation for 10 min at 500g. Dilutions of sera main- 
taining the indicated ratios of sera to cells were added to the pellet and incubated 60 min 
at 0°C. The tissue was removed by low-speed centrifugation (500 g for 10 min) and the 
absorbed sera cleared by higher speed centrifugation (10 000 g for 10 min), both at 4°C. 
Sperm were prepared and counted as previously described (Betlach and Erickson, 1973), 
pelleted and the supernatant discarded. 100 /zl of the dilution of antisera used for im- 
munofluorescence was added to the indicated number of spermatozoa and absorption 
continued as above. Fresh sheep red blood cells were washed twice with the above media, 
pelleted for 10 min at 800 g, and used for absorption. 
Preparation and treatment of embryos 
Pre-implantation embryos were obtained from crosses of heterozygotes for lethal mu- 
tations inter se. Such crosses are expected to yield homozygous lethal embryos (Table 1). 
Pre-implantation embryos were flushed in Whitten's medium (Whitten, 1957)from.the 
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Fig. 1. Delayed morulae from +#12 × +/t 12 cross on day 31 showing positive fluorescence with anti- 
F9 antiserum. 
oviducts (on day 2-~) or uteri (on day 3~) of timed pregnant females (noon of the day of 
finding the vaginal plug is taken as day ~ since insemination occurs, on the average, at 
midnight). The zona pellucida was removed by a 10 min incubation with 0.25% pronase 
and 1% PVP in PBS and the embryos were then washed twice and allowed to 'rest' at 37°C 
for 2 h in Whitten's medium in the CO2 incubator. They were then incubated for 1 h at 
4°C and an anti-F9 mouse serum (1/20 for the ascitic fluid, 1/10 for AS-7, and 1/20 for 
AS-9) and rinsed through three changes of medium. This was followed by a 1 h incubation at 
4°C in the FITC-rabbit anti-mouse IgG (1 : 10)and four more washes before exmaination 
with a Zeiss epi-iUumination fluorescence microscope. Controls included use of normal 
mouse sera at the same dilutions or no sera during the first incubation. Only cell surface 
staining (Fig. 1) was accepted as positive since dead cells of all kinds can be non-specifically 
filled with fluorescent material. All groups of pre-implantation embryos were read 'blind' 
with the observer not knowing what cross produced a given batch of embryos. The degree of 
immunofluorescence varies in embryos of the same genotype on different days and the 
classification of embryos as positive or negative involved a certain degree of subjectivity. 
Although lower dilutions of the anti-F9 ascites serum stained a certain percentage of +/+ 
embryos, the 1/20 dilution was used ~xtensively since it was the limiting dilution yielding 
high percentages of positive +/+ embryos. We consistently found higher percentages of 
embryos from all crosses to be positive on day 31; therefore day 3~ embryos were primar- 
ily studied in crosses involving the developmental lethals other than those in the T-region. 
RESULTS 
The antisera used in this study showed the reactivities, with +/+ embryos and sperma- 
tozoa but not with adult liver and spleen, which are expected for anti-F9 sera. As seen in 
Fig. 2, the reactivities with embryos of all 3 antisera used in this study were readily 
absorbed by spermatozoa prepared from wild-type mice. It has recently been found that 
the F9 cell line is not completely nullipotent and that parietal endoderm-like cells appear 
with low frequency (Sherman and Miller, 1978). Therefore, in many of our experiments 
297 
1 0 0  
a n t i -  F -  9 ,  splanocytes 
:1...-I. a n t i - F - g ,  + / +  sperm 
0 - . - 0  A S - 7 ,  + /+sperm 
~ ' A S - 9 ,  + /+sperm 
= - - - "  a n t i - F - 9 ,  $ R B C  
/ \  
geo  ~ \ 
| \.\ 
14o \ • . \ 
o \ 
• \ 
2 0  '. \. 
• .. \ 
• ' . . .  
I &\QI I "" ' Ill I I t t 
4 6 8 I0  
number of absorbing cells / 1 0 0  p l  s t n n d n r d  x 10 -7  
I J 
5 15 5 0  
p l S R B C  / 1 0 0  p l  . 0 5  a n t i - F - 9  
Fig. 2. Absorption of anti-F9 antisera with spermatozoa or other cells. Ordinate: percentage of wild- 
type embryos positive by immunofluorescence with the absorbed or control sera; abscissa: number of 
cells or volume of packed sheep red blood cells used for absorption. 
the antisera were further absorbed with primitive yolk sac (PYS) tumor to remove these 
possible cross-reacting specificities. In addition, primitive yolk sac specific antigens are 
not known to appear on the normal blastocyst; thus a component in the antisera cross- 
reacting with PYS should not be of concern. About equal numbers of embryos were 
studied with PYS-absorbed and spleen cell-absorbed anti-F9. Of 14 chi-square tests per- 
formed on the differences between the two absorptions, only one difference was statisti- 
caUy significant. Finally, Stern et al. (1978) and WiUison and Stern (1978) have identified 
a Forssman-type specificity (classically present on sheep red blood cells) shared by pre- 
implantation embryos, teratocarcinoma cells and spermatozoa. Our major antiserum's 
reactivity with pre-implantation embryos cannot be due to such a heterophilic compo- 
nent, since it could not be absorbed by sheep red blood cells (Fig. 2). 
A comparison of the expression of F9 antigen on normal embryos with its expression 
on a number of embryos carrying lethal mutations other than those at the T-locus can be 
seen in Table 2. Since the degree of reactivity was essentially the same whether the anti- 
F9 sera had been absorbed with spleen ceils or PYS tumor the data were pooled. All 20 
embryos from ceh/c2SH X c ch X c 2sH litters were positive on day 3~. These included 15 
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TABLE 2 
F9 antigen expression on pre-implantation embryos from crosses involving non-T-region develop- 
mental lethal mutations 
Cross Day 21 Day 31 
No. pos./total % Positive No. pos./total % Positive 
(No. litters) (No. litters) 
cch/c 2sH X cch/c 25H 
Cleavage-arrested 
embryos 4-8  cells 
Blastocysts 
+/Os x +/Os 
cch/c 6H X cCh/c 6H 
5/5 (3) 100 
15/15 (3) 100 
2/20 (2) 10 38/38 (6) 100 
3/14 (1) 21 37/37 (3) 100 
normal blastocysts as well as 5 embryos identified as  C 2 s H  homozygotes because of their 
arrest in early cleavage (Lewis, 1978) and their striking nuclear abnormalities observed in 
cytological preparations made after the fluorescence studies (S. Lewis, unpublished). 
The peri-implantation Os/Os homozygote (Van Valen, 1966) cannot consistently be 
distinguished morphologically from its normal littermates on day 321- of development 
without histological or cytological analysis. However, it is likely that this lethal homo- 
zygote also expresses F9 antigen. All 38 embryos from crosses of Os heterozygotes inter 
se express the antigen; 1/4 of these blastocysts are expected to be lethal Os/Os homo- 
zygotes (X 2 38/4 =~ 0 is 9.5, P < 0.01). 
In addition, we examined the expression of F9 antigen on 31-day-old embryos homo- 
zygous for c 6n, a post-implantation lethal mutation (Lewis et al., 1976). All 37 blasto- 
cysts reacted positively with the antiserum, among which must be included c 6H homo- 
zygotes (X: 37/4 ~ 0  is 9.25, P<0 .01 ) .  In at least one case, early post-implantation 
lethality is therefore not necessarily associated with a failure of expression of F9 antigen. 
A comparison of F9 antigen expression in embryos from a number of crosses involving 
t 12 which were performed on day 31 of development is shown in Table 3. +It 12 × +/t 12 
crosses should produce 36% t12/t 12 progeny because of the segregation ratio currently 
recorded for t12-carrying males in our colony. On day 31, 98% of the embryos from this 
cross-reacted with our ascites-derived antiserum and fluorescein labeled rabbit anti-mouse 
IgG (Table 3, row 1). 53% of these 3~--day-old embryos were at the morula stage (there 
were 29% 31-day morula in the control crosses) and these must include the tx2/t 12 em- 
bryos. Thus, we found no evidence for segregation of F9 antigen reactivity in crosses pro- 
ducing the t 12 homozygote at 3½ days of development. 
There was a possible effect of the T-region genotype of the male on the time of 
appearance of F9 antigen in these crosses involving t 12. If the father carries T, an effect 
on the expression of F9 antigen on day 21 was noted (Table 3). In the experimental 
crosses of Tit 12 × Tit 12 or +/t 12 X Tit 12 in which T was transmitted by the father, only 






















































































































































































































































































































































F9 antigen expression on 3~-day embryos using alternative antisera 





AS-7 (129 anti-F9) 1/10 +/+ X +/+ 3 10/10 14/15 96 
1/10 +#12 X +#12 5 15/15 5/13 71 
AS-9 (CBA/HN X 1/20 +/+ X +/+, 3 12/15 18/21 83 
129/JF anti-F9) T/+ X +#12 
1/20 +/t 12 X +/t 12 3 22/30 9/15 64 
Anti-F9 with anti- 
mouse lgM as 
second layer 1/20, 1/10 a +/+ X +/+ 1 6/6 - 100 
1/20, 1/10 a +/t 12 X +#12 1 6/7 9/9 94 
a Anti-F9 was 1/20, anti-mouse IgM was 1/10. 
when the father did not carry T. This apparent effect of  a T-carrying father was also seen 
in control crosses where no t 12~tin embryos were involved. 83% of  embryos whose father 
did not transmit T were positive on days 2~ (Table 3, row 3) while 38% of  embryos were 
positive on day 2½ when T was inherited from the father (Table 3, row 4). Thus it appears 
that T Carried by the father, but not the mother, delays expression of  the F9 antigen. 
The reactivity o f  antisera from other sources was also studied on t 12/t12 embryos from 
the same crosses (Table 4). Both AS-7 and AS-9 gave lower percentages of  positively 
reacting embryos in crosses where t 12 homozygotes would be present than in control 
crosses but the deficiency was as severe, or more so, for blastocysts (among which there 
cannot be any t12/t m embryos) as for morulae (which include both t12/t12 and normally 
delayed embryos). Since a monoclonal antibody to the F9 teratocarcinoma is IgM (SoRer 
and Knowles, 1978), we have also tested the reactivity of  our major antiserum using anti- 
IgM as the second reagent. The results were no different than those found when using 
anti-IgG in both +/t 12 X +/t 12 and control crosses. Thus, two other anti-F9 antisera and a 
different second antibody failed to provide evidence for the absence of  F9 antigen in 
t 12/tl 2 embryos. 
We also tested reactivity of  our anti-F9 serum with two other T-region mutants. Our 
studies of  embryos from crosses involving t ws, a lethal at the egg cylinder stage, where 
nearly half the embryos should be homozygous t ws because of  the high segregation dis- 
tortion of  t ws, show 65% reactivity with the anti-F9 antiserum. This represents a 29% 
deficiency compared to the controls involving the t ws stock. 
Tot 1 is a deletion in the T-region which extends for at least 3 centimorgans from T to 
quaking (Erickson et al., 1978). As seen in Table 5, 81% of  36 embryos from crosses 
expected to produce 25% T°r l /T  ° r l  were positive on day 33. This is a 19% deficiency 
from controls involving T ° r l  stock. Thus, T ° r l  homozygotes, expected as 25% of  the 
progeny, may not express F9 antigen on day 321- o f  development. 
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TABLE 5 
F9 antigen expression on pre-implantation embryos from crosses involving post-implantation T- 
region mutants a 
1 Cross Day 35 Total Probability 
No. pos./total % positive of difference 
(No. litters) 
Homozygous t w5 present 
(tw5/+ × tWS/T, tws/+ X tws/+) 
Control (+/t w5 × T/+) 
Homozygous T Orl present 
(+/T Orl X +/T Orl) 
Control (+/+ X +/T Orl) 
23/35 (6) 65 
×2 = 3.86, 
30/32 (2) 94 
29/36(3) 81 
x 2 = 1.5, 
30/30 (2) 100 
P < 0.05 
P>0.1 
a Anti-F9 absorbed on PYS tumor was used. 
DISCUSSION 
The results of  this study clearly show a normal frequency of F9 antigen expression on 
embryos homozygous for mutant genes causing embryonic lethality at several stages of  
development: (1) cleavage - c 2sH, (2) morula - t 12, (3) peri-implantation - Os, and (4) 
egg cylinder - c 6H. We were not able to establish clearly whether embryos homozygous 
for two other T-region variants, T ° r l  and t ws, showed normal expression of the F9 anti- 
gen. 
The reasons for the discrepancy between our results on t 12 homozygous embryos and 
those of Kemler et al. (1976) are not dear. We used 3 different F9 antisera, all with the 
same apparent specificities as theirs. Hillman and HiUman (1975) have shown in studies 
with transmission electron microscopy that twa2/t wa2 embryos are distinguishable from 
t l2/t  12 embryos, even though t 12 and t w32 are in the same complementation group. 
Altho~g,h initially referred to as t 12, the Pasteur group has always used t w32 whereas our 
studies were carried out with t ~2. A possible difference of alleles or minor differences in 
technique could be the explanation for the discrepancy. However, Marticorena et al. 
(1978) consistently found no differences in the reactivity of  embryos homozygous for 
t w32 and t 12 with anti-F9. Dewey et al. (1977)have recently reported that the antigen(s) 
determined by an antiserum against testicular teratocarcinoma embryoid bodies was pres- 
ent on t12/t ~2 embryos (t 12 belongs to the same complementation group as t w32) but 
their sera had differences in specificity compared to anti-F9 as it did not cross-react with 
sperm. 
It is interesting to speculate whether the T-region controls antigens. In a preliminary 
communication in 1949, Caspari and Dalton presented data suggestihg that an antigen 
present in soluble extracts of  testes was controlled by T. However, antisera which had 
been raised in rabbits and the putative T-specific antigen were apparently not studied fur- 
ther. In 1957, Gluecksohn-Waelsch proposed that t-alleles might alter cell surface specific- 
ities, and in 1971 Gluecksohn-Waelsch and Erickson refined the immunological hypothe- 
sis for T-region effects to state that cell surface antigens present on sperm and embryos 
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might be controlled by this region. Evidence for T-region determined antigens on sperm 
has been presented from one laboratory (Bennett et al., 1972; Yanagisawa et al., 1974; 
Artzt and Bennett, 1977) but other laboratories have not been able to confirm these find- 
ings. In one extensive report, T-region determined antigens could not be found on sper- 
matozoa by numerous antiglobulin tests (Goodfellow et al., 1979). However, this is not 
the immunological test used in the positive reports, which utilized a direct sperm cyto- 
toxicity test. Thus, further negative results with a sperm cytotoxicity test are more im- 
portant (Gable et al., 1979). It is currently a moot point whether there are T-region anti- 
gens expressed on spermatozoa. 
A second approach has related teratocarcinoma antigens to the T-region. The evidence 
in favor of the F9 antigen being determined by a structural gene at the wild-type allele of 
the t 12 mutation has been reviewed above. We have not been able to confirm that part of  
the evidence which relates to segregation of F9 antigen in embryos from crosses involving 
t ~2. Thus, there is no consistent evidence that teratocarcinoma antigens are coded by 
genes in the T-region. 
On the other hand, any large chromosomal region could include genes for several cell 
surface proteins. Recent data (Erickson et al., 1978) which indicate that the T-region may 
extend for six centimorgans on chromosome 17 encourages one to believe that more than 
one antigen could be determined in this region. Loci coding for minor histocompatibil- 
ity antigens are found with high density near the H-2 region (Flaherty, 1975 ; Artzt et al., 
1977) which is only 5 centimorgans from the tufted region to which embryonic lethal 
effects of t-alleles seem to map (Lyon and Bechtol, 1977). Furthermore, studies in m a n -  
mouse somatic hybrids which retain only one heterospecific chromosome have shown 
that each such hybrid contains cell surface antigens coded for by the heterospecific chro- 
mosome (Kao et al., 1977; Dorman et al., 1978). Thus, it would not be surprising if some 
further refinements in technique or approach will allow the detection of cell surface anti- 
gens coded for by genes in the T-region. It will then be necessary to determine the possi- 
ble relationship between such antigens and the many interesting biological properties of 
the T-region. 
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